Literature DB >> 19119262

Association of SLC34A2 variation and sodium-lithium countertransport activity in humans and baboons.

Xiaojing Zheng1, Candace M Kammerer, Laura A Cox, Alanna Morrison, Stephen T Turner, Robert E Ferrell.   

Abstract

BACKGROUND: Sodium-lithium countertransport (SLC) activity, an intermediate phenotype of essential hypertension, has been linked to a region of baboon chromosome 5, homologous to human chromosome 4p. Human SLC34A2, located at chromosome 4p15.1-p15.3, is a positional candidate gene for SLC. The specific aim of this study was to identify genetic variants of the SLC34A2 gene in both baboon and human, and to examine the relationship of these polymorphisms with SLC activity and blood pressure.
METHODS: Single-nucleotide polymorphism (SNP) was identified by sequencing the SLC34A2 gene in 24 baboon founders and 94 unrelated individuals. All tag SNPs in SLC34A2 were genotyped in 1,856 individuals from 252 pedigrees of mixed European ancestry. Three SNPs in baboon were genotyped in 634 baboons comprising 11 pedigrees.
RESULTS: In human, one SNP (rs12501856) was found to be significantly associated with SLC individually, though it did not pass multiple testing correction; however, haplotype 2 containing allele C of SNP rs12501856 showed strong evidence of association with SLC (P = 0.0037) after multiple comparison adjustment. This haplotype was also marginally associated with diastolic blood pressure and systolic blood pressure. This finding was confirmed in baboons, where a highly significant association was detected between SLC and baboon SNP Asn136Asn (P = 0.0001). However, the associated SNP did not account for the linkage signal on baboon chromosome 5.
CONCLUSIONS: Consistent results in two different species imply that SLC34A2 is associated with SLC activity and blood pressure.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19119262      PMCID: PMC2652891          DOI: 10.1038/ajh.2008.355

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  38 in total

1.  A prospective study of sodium-lithium countertransport and hypertension in Utah.

Authors:  S C Hunt; S H Stephenson; P N Hopkins; S J Hasstedt; R R Williams
Journal:  Hypertension       Date:  1991-01       Impact factor: 10.190

2.  Molecular evidence of genetic heterogeneity in Wistar-Kyoto rats: implications for research with the spontaneously hypertensive rat.

Authors:  T W Kurtz; M Montano; L Chan; P Kabra
Journal:  Hypertension       Date:  1989-02       Impact factor: 10.190

3.  Analysis of the distribution of erythrocyte sodium lithium countertransport in a sample representative of the general population.

Authors:  E Boerwinkle; S T Turner; R Weinshilboum; M Johnson; E Richelson; C F Sing
Journal:  Genet Epidemiol       Date:  1986       Impact factor: 2.135

4.  Increased sodium-lithium countertransport in red cells of patients with essential hypertension.

Authors:  M Canessa; N Adragna; H S Solomon; T M Connolly; D C Tosteson
Journal:  N Engl J Med       Date:  1980-04-03       Impact factor: 91.245

5.  Red blood cell lithium-sodium countertransport in the tecumseh blood pressure study.

Authors:  A B Weder; N J Schork; L Krause; S Julius
Journal:  Hypertension       Date:  1991-05       Impact factor: 10.190

6.  Sodium-lithium countertransport genotype and the probability of hypertension in adults.

Authors:  T R Rebbeck; S T Turner; C F Sing
Journal:  Hypertension       Date:  1993-10       Impact factor: 10.190

7.  Sodium-lithium countertransport and hypertension in Rochester, Minnesota.

Authors:  S T Turner; V V Michels
Journal:  Hypertension       Date:  1991-08       Impact factor: 10.190

8.  Hypertension and sodium-lithium countertransport in Utah pedigrees: evidence for major-locus inheritance.

Authors:  S J Hasstedt; L L Wu; K O Ash; H Kuida; R R Williams
Journal:  Am J Hum Genet       Date:  1988-07       Impact factor: 11.025

9.  Distribution of sodium-lithium countertransport and blood pressure in Caucasians five to eighty-nine years of age.

Authors:  S T Turner; W H Weidman; V V Michels; T J Reed; C L Ormson; T Fuller; C F Sing
Journal:  Hypertension       Date:  1989-04       Impact factor: 10.190

10.  Sodium-lithium countertransport and blood pressure in healthy blood donors.

Authors:  S T Turner; M Johnson; E Boerwinkle; E Richelson; H F Taswell; C F Sing
Journal:  Hypertension       Date:  1985 Nov-Dec       Impact factor: 10.190

View more
  2 in total

1.  Microbiota-governed microRNA-204 impairs endothelial function and blood pressure decline during inactivity in db/db mice.

Authors:  Ravinder Reddy Gaddam; Veronica Peotta Jacobsen; Young-Rae Kim; Mohanad Gabani; Julia S Jacobs; Karishma Dhuri; Santosh Kumar; Modar Kassan; Qiuxia Li; Raman Bahal; Robert Roghair; Kaikobad Irani; Ajit Vikram
Journal:  Sci Rep       Date:  2020-06-22       Impact factor: 4.379

2.  Elevated expression of SLC34A2 inhibits the viability and invasion of A549 cells.

Authors:  Weihan Yang; Yu Wang; Qiang Pu; Sujuan Ye; Qingping Ma; Jiang Ren; Guoxing Zhong; Lunxu Liu; Wen Zhu
Journal:  Mol Med Rep       Date:  2014-07-14       Impact factor: 2.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.